The government touted a response based on science and data but a surge is showing otherwise
Rigor académico, oficio periodístico
Artículos sobre Science and innovation for development
Mostrando 101 - 120 de 220 artículos
Staging this conference in all time zones with fair distribution of prime-time events was no small feat. But the exchange of ideas, experiences and solutions remained a strong priority.
South African businesses have typically invested in innovation activities that help them prepare for technological and organisational change.
COVID-19 antibody tests can’t replace the use of PCR tests in people showing symptoms. But they can help test people who may be infected and asymptomatic.
Kenya’s new internet balloons could help to get more Kenyans online and drive new industry.
An ideal test for the diagnosis of COVID-19 would be cheap, accurate and easy to use. The key is to choose an affordable test with the strengths and limitations meet a population’s needs.
There isn’t enough clinical research being done in Africa. This has had a lot of repercussions in terms of the timing when interventions become available and effective in high income countries.
Vaccine development usually spans a number of decades. This is because there’s a need to understand the mechanisms of protection against the pathogen, and to minimise adverse reactions.
In a pandemic like this one, the priority is to save lives. But without a vaccine, there’s a limit in the tools available to save lives.
History shows that treatments and vaccines have been accessible to African countries only after the loss of millions of lives and typically years - sometimes decades - after developed nations.
In a country marred by systematic discrimination and continued social marginalisation, particular consideration needs to be given to the measures being used to contain the spread of COVID-19.
African policymakers should strenuously safeguard their right to choose from the widest possible range of technology options that suit their countries’ development needs.
One of the methods researchers are exploring to combat COVID-19 is gene editing: altering the genome of the virus to make it harmless.
There has been a rapid redirection of resources towards COVID-19-related research. In the long term, this resource reallocation is likely to result in budget cuts in all research areas.
Mobile technology has great potential to improve healthcare in Nigeria but government must provide regulatory framework.
A crisis like COVID-19 demands that professional barriers be broken.
Findings that are effectively communicated can go a long way to serve the interests of the public. They can help to address social injustices or improve treatments offered to patients.
While there are various good reasons for doing research and funding research, the chief reason is that research provides essential insurance against catastrophic events.
Africa is better prepared now to perform research in emerging infections than during the Ebola epidemics in West Africa.
Empatheatre’s latest production is more than a play about three characters who live near the sea. It’s a model for collective consultation on how to save the ocean.
Principales colaboradores
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town
-
Professor of the Practice of International Development, Harvard Kennedy School
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Tutorial Fellow, School of Medicine, University of Nairobi, University of Nairobi
-
Associate Professor at the University of Pretoria and Co-ordinator of the South African SDG Hub, University of Pretoria
-
Post Doctoral Fellow, University of KwaZulu-Natal
-
Professor in Biochemistry, Genetics and Microbiology, and Professor at Future Africa, University of Pretoria, University of Pretoria
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Director, Institute for Cellular and Molecular Medicine & SAMRC Extramural Unit for Stem Cell Research & Therapy, University of Pretoria
-
Director of Science, Ifakara Health Institute
-
Head of the Division of Pulmonology, University of Cape Town
-
Fellow, Nigerian Academy of Science
